Ibrutinib Racemate | CAS 936563-87-0 - Request Quote
Ibrutinib Racemate
| SZ CAT No: | SZ-I005067 |
| CAS No | 936563-87-0 |
| Mol.F. | C25H24N6O2 |
| Mol.Wt. | 440.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Racemate is chemically 1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. Ibrutinib Racemate is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Racemate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 936563-87-0
Purchase 936563-87-0
Order 936563-87-0
Enquire 936563-87-0
price of 936563-87-0
936563-87-0 Supplier
936563-87-0 Manufacturer
936563-87-0 Exporter
buy high quality Ibrutinib Racemate
Purchase Ibrutinib Racemate
Ibrutinib Racemate suppliers
Ibrutinib Racemate manufacturers
Ibrutinib Racemate price
Order Ibrutinib Racemate
Enquire Ibrutinib Racemate
Ibrutinib Racemate cost
Ibrutinib Racemate Supplier
Ibrutinib Racemate Distributor
Ibrutinib Racemate for Method Validation
Ibrutinib Reference Standard
Ibrutinib Racemate for ANDA Filing
Ibrutinib Racemate for Forced Degradation Studies
Ibrutinib Racemate Identification Standards
Ibrutinib Racemate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


